News
In the Portal study (n = 352), people originally treated with Susvimo in Archway continued to receive Susvimo refills every six months (Susvimo cohort; n = 220), while those originally treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback